Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insights

Set Alert for Digital Health

Minute Insight: Apple Watch Helps Knee-Replacement Patients In Zimmer Biomet-Sponsored Trial

One-year data from a randomized controlled trial showed Zimmer Biomet’s mymobility app paired with the Apple Watch can effectively guide rehabilitation following knee-replacement surgery.

Minute Insights Digital Health

Minute Insight: Trials Sponsored By Medtronic and Biosense Webster Show Benefits Of AFib Ablation

Results from two industry-supported clinical trials published in the last week offer more support for treating atrial fibrillation with catheter ablation rather than medication alone.

Minute Insights Clinical Trials

Minute Insight: Carta Healthcare Raised $20M In Series B To Build Out AI-Driven Clinical Data Solutions

Carta Healthcare said it will use its new funding to expand its solutions into hospitals.

Minute Insights Financing

Minute Insight: Thermo Fisher Buys Diagnostics Company The Binding Site For $2.6Bn

Birmingham, UK-based The Binding Site and its 1,100 employees will now fall under Thermo Fisher’s expanding umbrella.

Minute Insights M & A

Minute Insight: Indigo Diabetes Starts Human Trial Of Subcutaneous Glucose Monitor

The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.

Minute Insights Diabetic Care

Minute Insight: Thermo Fisher Gets FDA OK On Cancer Companion Diagnostic

The US FDA has approved additional indications for Thermo Fisher Scientific’s Oncomine Dx Target, allowing the companion diagnostic to be used to detect more varieties of lung and thyroid cancer.

Minute Insights Personalized Medicine

Minute Insight: Smith + Nephew Expands VR-based Surgical Training

Smith + Nephew is expanding its suite of simulation technologies to train surgeons on new techniques before they enter the operating room.

Minute Insights Orthopedics

Minute Insight: Hedera DX Completes €14m Raise To Fund ML-Backed Liquid Biopsy Tech

Hedera DX’s liquid biopsy test uses machine learning to recommend drugs to patients based on a tumor’s circulating DNA profile.

Minute Insights Cancer
See All
UsernamePublicRestriction

Register